Draghia-Akli Ruxandra — SEC Form 4 filings

SEC reporting owner CIK 2041719. 5 Form 4 filings on record with FilingPulse; latest filed 2026-03-09.

Transaction summary — filings shown

Covers all 5 filings on record, filed 2024-11-13 to 2026-03-09. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
NOVAVAX INC (NVAX)EVP, Research & Development513

Form 4 filings — Draghia-Akli Ruxandra

FiledFormIssuerReported transactionsSource
2026-03-094/ANOVAVAX INC (NVAX)Grant/award (A): 139,500 (derivative) @ $0EDGAR
2026-03-054NOVAVAX INC (NVAX)Option exercise (M): 26,667 @ $0 · Tax withholding (F): 11,313 @ $9.49 · Grant/award (A): 93,000 (derivative) @ $0 · Grant/award (A): 139,500 (derivative) @ $9.09 · Disposition to issuer (D): 26,667 (derivative) @ $0EDGAR
2025-11-134NOVAVAX INC (NVAX)Option exercise (M): 14,257 @ $0 · Tax withholding (F): 6,048 @ $7.40 · Disposition to issuer (D): 14,257 (derivative) @ $0EDGAR
2025-03-054NOVAVAX INC (NVAX)Grant/award (A): 120,000 (derivative) @ $7.87 · Grant/award (A): 80,000 (derivative) @ $0EDGAR
2024-11-134NOVAVAX INC (NVAX)Grant/award (A): 64,150 (derivative) @ $9.01 · Grant/award (A): 42,770 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2041719 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →